FDX2 and metabolic myopathy: In support of this hypothesis, biallelic mutations in the FDX2 gene (FDX1L) have already been identified in patients with metabolic myopathy with deficiencies in various complexes of the ETC, suggestive of mitochondrial Fe–S-related defects15.